BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 15583332)

  • 1. False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide.
    Woo PC; Lau SK; Wong BH; Chan KH; Hui WT; Kwan GS; Peiris JS; Couch RB; Yuen KY
    J Clin Microbiol; 2004 Dec; 42(12):5885-8. PubMed ID: 15583332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia.
    Woo PC; Lau SK; Wong BH; Tsoi HW; Fung AM; Kao RY; Chan KH; Peiris JS; Yuen KY
    J Clin Microbiol; 2005 Jul; 43(7):3054-8. PubMed ID: 16000415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid-based western blot assay were rectified by the use of two subunits (S1 and S2) of spike for detection of antibody to SARS-CoV.
    Maache M; Komurian-Pradel F; Rajoharison A; Perret M; Berland JL; Pouzol S; Bagnaud A; Duverger B; Xu J; Osuna A; Paranhos-BaccalĂ  G
    Clin Vaccine Immunol; 2006 Mar; 13(3):409-14. PubMed ID: 16522785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of antibody responses against SARS coronaviral nucleocapsid or spike proteins by immunoblotting or ELISA.
    Huang LR; Chiu CM; Yeh SH; Huang WH; Hsueh PR; Yang WZ; Yang JY; Su IJ; Chang SC; Chen PJ
    J Med Virol; 2004 Jul; 73(3):338-46. PubMed ID: 15170626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of specific antibodies against SARS-coronavirus nucleocapsid protein without cross reactivity with human coronaviruses 229E and OC43.
    Lee HK; Lee BH; Seok SH; Baek MW; Lee HY; Kim DJ; Na YR; Noh KJ; Park SH; Kumar DN; Kariwa H; Nakauchi M; Heo SJ; Park JH
    J Vet Sci; 2010 Jun; 11(2):165-7. PubMed ID: 20458159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant protein-based assays for detection of antibodies to severe acute respiratory syndrome coronavirus spike and nucleocapsid proteins.
    Haynes LM; Miao C; Harcourt JL; Montgomery JM; Le MQ; Dryga SA; Kamrud KI; Rivers B; Babcock GJ; Oliver JB; Comer JA; Reynolds M; Uyeki TM; Bausch D; Ksiazek T; Thomas W; Alterson H; Smith J; Ambrosino DM; Anderson LJ
    Clin Vaccine Immunol; 2007 Mar; 14(3):331-3. PubMed ID: 17229882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an enzyme-linked immunosorbent assay-based test with a cocktail of nucleocapsid and spike proteins for detection of severe acute respiratory syndrome-associated coronavirus-specific antibody.
    Giménez LG; Rojas J; Rojas A; Mendoza J; Camacho AG
    Clin Vaccine Immunol; 2009 Feb; 16(2):241-5. PubMed ID: 19038782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of a reference panel for the detection of anti-SARS-CoV antibodies.
    Liu C; Li X; Zhang C; Xu S; Shao Y; Zhuang H; Che X; Qiu Y; Yin H; Li D; Wang Y
    Biologicals; 2007 Jun; 35(3):203-10. PubMed ID: 17261372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiles of IgG antibodies to nucleocapsid and spike proteins of the SARS-associated coronavirus in SARS patients.
    Wang Y; Chang Z; Ouyang J; Wei H; Yang R; Chao Y; Qu J; Wang J; Hung T
    DNA Cell Biol; 2005 Aug; 24(8):521-7. PubMed ID: 16101351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression and antigenicity of a truncated spike-nucleocapsid fusion protein of severe acute respiratory syndrome-associated coronavirus.
    Mu F; Niu D; Mu J; He B; Han W; Fan B; Huang S; Qiu Y; You B; Chen W
    BMC Microbiol; 2008 Nov; 8():207. PubMed ID: 19038059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel immunofluorescence assay using recombinant nucleocapsid-spike fusion protein as antigen to detect antibodies against severe acute respiratory syndrome coronavirus.
    He Q; Manopo I; Lu L; Leung BP; Chng HH; Ling AE; Chee LL; Chan SW; Ooi EE; Sin YL; Ang B; Kwang J
    Clin Diagn Lab Immunol; 2005 Feb; 12(2):321-8. PubMed ID: 15699428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination and application of immunodominant regions of SARS coronavirus spike and nucleocapsid proteins recognized by sera from different animal species.
    Yu M; Stevens V; Berry JD; Crameri G; McEachern J; Tu C; Shi Z; Liang G; Weingartl H; Cardosa J; Eaton BT; Wang LF
    J Immunol Methods; 2008 Feb; 331(1-2):1-12. PubMed ID: 18191140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia.
    Woo PC; Lau SK; Tsoi HW; Chan KH; Wong BH; Che XY; Tam VK; Tam SC; Cheng VC; Hung IF; Wong SS; Zheng BJ; Guan Y; Yuen KY
    Lancet; 2004 Mar; 363(9412):841-5. PubMed ID: 15031027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus.
    Woo PC; Lau SK; Wong BH; Chan KH; Chu CM; Tsoi HW; Huang Y; Peiris JS; Yuen KY
    Clin Diagn Lab Immunol; 2004 Jul; 11(4):665-8. PubMed ID: 15242938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antigenicity analysis of nucleocapsid proteins of 3 human coronaviruses SARS-CoV, 229E and OC43 with their monoclonal antibodies].
    Qiu LW; Wang YD; Liao ZY; Wen K; Che XY
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):290-3. PubMed ID: 16546729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV spike proteins expressed by the vaccinia virus Tiantan strain: secreted sq protein induces robust neutralization antibody in mice.
    Yan K; Tan W; Wang H; Wang Y; Zhang X; Li Y; Ruan L
    Viral Immunol; 2009 Feb; 22(1):57-66. PubMed ID: 19210229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-way antigenic cross-reactivity between severe acute respiratory syndrome coronavirus (SARS-CoV) and group 1 animal CoVs is mediated through an antigenic site in the N-terminal region of the SARS-CoV nucleoprotein.
    Vlasova AN; Zhang X; Hasoksuz M; Nagesha HS; Haynes LM; Fang Y; Lu S; Saif LJ
    J Virol; 2007 Dec; 81(24):13365-77. PubMed ID: 17913799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.
    Shrwani K; Sharma R; Krishnan M; Jones T; Mayora-Neto M; Cantoni D; Temperton NJ; Dobson SL; Subramaniam K; McNamara PS; Cunliffe NA; Turtle L; Zhang Q
    J Infect Dis; 2021 Oct; 224(8):1305-1315. PubMed ID: 34161567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative and sensitive detection of the SARS-CoV spike protein using bispecific monoclonal antibody-based enzyme-linked immunoassay.
    Sunwoo HH; Palaniyappan A; Ganguly A; Bhatnagar PK; Das D; El-Kadi AO; Suresh MR
    J Virol Methods; 2013 Jan; 187(1):72-8. PubMed ID: 22995576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43.
    Che XY; Qiu LW; Liao ZY; Wang YD; Wen K; Pan YX; Hao W; Mei YB; Cheng VC; Yuen KY
    J Infect Dis; 2005 Jun; 191(12):2033-7. PubMed ID: 15897988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.